NIH opportunities relevant to SARS-COV-2 (COVID-19).
From the NIH Guide for the week ending August 7, 2020.

• Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed)
  (RFA-OD-20-014)
  Application Receipt Date(s): September 15, 2020.
• Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 - Clinical Trials Not Allowed)
  (RFA-OD-20-015)
  Application Receipt Date(s): September 15, 2020.
• Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional)
  (RFA-OD-20-016)
  Application Receipt Date(s): September 30, 2020.
• Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed)
  Limited to one submission per institution: UIowa Limited Submission Procedure:  https://uiowa.infoready4.com/#competitionDetail/1821952
  (RFA-OD-20-017)
  Internal deadline: Wednesday, August 26 (11:59 PM)
  NIH deadline: Friday, September 18, 2020.
  Limitation: one per institution
   
• Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed)
  Limited to one submission per institution: UIowa Limited Submission Procedure:  https://uiowa.infoready4.com/#competitionDetail/1821949
  (RFA-OD-20-018)
  Internal deadline: Wednesday, August 26 (11:59 PM)
  NIH deadline: Friday, September 18, 2020.
  Limitation: one per institution
   
• Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed)
  Limited to one submission per institution: UIowa Limited Submission procedure:  https://uiowa.infoready4.com/#competitionDetail/1821954
  (RFA-OD-20-019)
  Internal deadline: Wednesday, August 26 (11:59 PM)
  NIH deadline: Friday, September 30, 2020.
  Limitation: one per institution
   
• Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed)
  (RFA-OD-20-020)
  Application Receipt Date(s): September 18, 2020
• Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)
  (RFA-OD-20-021)
  Application Receipt Date(s): September 18, 2020
• Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional)
  (RFA-OD-20-022)
  Application Receipt Date(s): September 15, 2020.   
• Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)
  (RFA-OD-20-023)
  Application Receipt Date(s): September 30, 2020.
• Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required)
  (RFA-TR-20-003)
  Applications will be accepted on a rolling basis, beginning on August 6, 2020.